table of content
1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid Based Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid Based Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid Based Gene Therapy Overall Market Size
2.1 Global Nucleic Acid Based Gene Therapy Market Size: 2022 VS 2032
2.2 Global Nucleic Acid Based Gene Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nucleic Acid Based Gene Therapy Players in Global Market
3.2 Top Global Nucleic Acid Based Gene Therapy Companies Ranked by Revenue
3.3 Global Nucleic Acid Based Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Nucleic Acid Based Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nucleic Acid Based Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nucleic Acid Based Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Nucleic Acid Based Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Nucleic Acid Based Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nucleic Acid Based Gene Therapy Market Size Markets, 2022 & 2032
4.1.2 Anti-Sence and Anti-Gene
4.1.3 Short Inhibitory Sequences
4.1.4 Gene Transfer Therapy
4.1.5 Nucleoside Analogs
4.1.6 Ribozymes
4.1.7 Aptamers
4.1.8 Others
4.2 By Type - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Nucleic Acid Based Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Nucleic Acid Based Gene Therapy Revenue, 2024-2032
4.2.3 By Type - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nucleic Acid Based Gene Therapy Market Size, 2022 & 2032
5.1.2 Hospitals and Clinics
5.1.3 Academic and Research Institutes
5.1.4 Others
5.2 By Application - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Nucleic Acid Based Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Nucleic Acid Based Gene Therapy Revenue, 2024-2032
5.2.3 By Application - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Nucleic Acid Based Gene Therapy Market Size, 2022 & 2032
6.2 By Region - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Nucleic Acid Based Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Nucleic Acid Based Gene Therapy Revenue, 2024-2032
6.2.3 By Region - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.3.2 US Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.3.3 Canada Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.3.4 Mexico Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.4.2 Germany Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.3 France Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.4 U.K. Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.5 Italy Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.6 Russia Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.8 Benelux Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.5.2 China Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5.3 Japan Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5.4 South Korea Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5.6 India Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.6.2 Brazil Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.6.3 Argentina Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.7.2 Turkey Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.7.3 Israel Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.7.5 UAE Nucleic Acid Based Gene Therapy Market Size, 2018-2032
7 Nucleic Acid Based Gene Therapy Companies Profiles
7.1 Wave Life Sciences
7.1.1 Wave Life Sciences Company Summary
7.1.2 Wave Life Sciences Business Overview
7.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Major Product Offerings
7.1.4 Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Wave Life Sciences Key News & Latest Developments
7.2 Imugene
7.2.1 Imugene Company Summary
7.2.2 Imugene Business Overview
7.2.3 Imugene Nucleic Acid Based Gene Therapy Major Product Offerings
7.2.4 Imugene Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 Imugene Key News & Latest Developments
7.3 Sarepta Therapeutics
7.3.1 Sarepta Therapeutics Company Summary
7.3.2 Sarepta Therapeutics Business Overview
7.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Major Product Offerings
7.3.4 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Sarepta Therapeutics Key News & Latest Developments
7.4 Alnylam Pharmaceuticals
7.4.1 Alnylam Pharmaceuticals Company Summary
7.4.2 Alnylam Pharmaceuticals Business Overview
7.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Major Product Offerings
7.4.4 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.5 Ionis Pharmaceuticals
7.5.1 Ionis Pharmaceuticals Company Summary
7.5.2 Ionis Pharmaceuticals Business Overview
7.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Major Product Offerings
7.5.4 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Ionis Pharmaceuticals Key News & Latest Developments
7.6 Moderna
7.6.1 Moderna Company Summary
7.6.2 Moderna Business Overview
7.6.3 Moderna Nucleic Acid Based Gene Therapy Major Product Offerings
7.6.4 Moderna Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 Moderna Key News & Latest Developments
7.7 BioNTech
7.7.1 BioNTech Company Summary
7.7.2 BioNTech Business Overview
7.7.3 BioNTech Nucleic Acid Based Gene Therapy Major Product Offerings
7.7.4 BioNTech Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 BioNTech Key News & Latest Developments
7.8 Nutcracker Therapeutics
7.8.1 Nutcracker Therapeutics Company Summary
7.8.2 Nutcracker Therapeutics Business Overview
7.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Major Product Offerings
7.8.4 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Nutcracker Therapeutics Key News & Latest Developments
7.9 Deep Genomics
7.9.1 Deep Genomics Company Summary
7.9.2 Deep Genomics Business Overview
7.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Major Product Offerings
7.9.4 Deep Genomics Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 Deep Genomics Key News & Latest Developments
7.10 Sirnaomics
7.10.1 Sirnaomics Company Summary
7.10.2 Sirnaomics Business Overview
7.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Major Product Offerings
7.10.4 Sirnaomics Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 Sirnaomics Key News & Latest Developments
7.11 Laronde
7.11.1 Laronde Company Summary
7.11.2 Laronde Business Overview
7.11.3 Laronde Nucleic Acid Based Gene Therapy Major Product Offerings
7.11.4 Laronde Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 Laronde Key News & Latest Developments
7.12 Abogen Biosciences
7.12.1 Abogen Biosciences Company Summary
7.12.2 Abogen Biosciences Business Overview
7.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Major Product Offerings
7.12.4 Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 Abogen Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
